Summary of Significant Accounting Policies (Tables)
|
9 Months Ended |
Sep. 30, 2022 |
|---|
| Accounting Policies [Abstract] |
|
| Schedule of Other Receivables |
|
|
|
|
|
|
|
|
|
As of |
|
|
September 30, 2022 |
|
|
December 31, 2021 |
|
Payroll tax withholding and exercise proceeds receivable |
$ |
9 |
|
|
$ |
8,477 |
|
Construction receivable |
|
8,034 |
|
|
|
5,574 |
|
Income tax receivable |
|
1,891 |
|
|
|
4,935 |
|
Insurance receivable |
|
2,977 |
|
|
|
2,594 |
|
Other |
|
1,530 |
|
|
|
1,216 |
|
Total other receivables |
$ |
14,441 |
|
|
$ |
22,796 |
|
|
| Schedule of Inventory |
Inventory consisted of the following for the periods presented:
|
|
|
|
|
|
|
|
|
As of |
|
|
September 30, 2022 |
|
|
December 31, 2021 |
|
Chemical washing solutions |
$ |
9,063 |
|
|
$ |
6,406 |
|
Other |
|
- |
|
|
|
52 |
|
Total inventory, gross |
|
9,063 |
|
|
|
6,458 |
|
Reserve for obsolescence |
|
(175 |
) |
|
|
(124 |
) |
Total inventory, net |
$ |
8,888 |
|
|
$ |
6,334 |
|
|
| Schedule of Composition of Revenue |
The following table summarizes the composition of the Company’s net revenues for the periods presented:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
|
Nine Months Ended September 30, |
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
Recognized over time |
$ |
150,873 |
|
|
$ |
127,825 |
|
|
$ |
440,809 |
|
|
$ |
358,456 |
|
Recognized at a point in time |
|
66,590 |
|
|
|
66,026 |
|
|
|
220,420 |
|
|
|
206,087 |
|
Other revenue |
|
113 |
|
|
|
459 |
|
|
|
925 |
|
|
|
2,355 |
|
Net revenues |
$ |
217,576 |
|
|
$ |
194,310 |
|
|
$ |
662,154 |
|
|
$ |
566,898 |
|
|
| Schedule of Reconciliations of Numerators and Denominators of Basic and Diluted Net (Loss) Income Per Share |
Reconciliations of the numerators and denominators of the basic and diluted net income per share calculations for the periods presented are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
|
Nine Months Ended September 30, |
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
Numerator: |
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
$ |
23,997 |
|
|
$ |
27,366 |
|
|
$ |
95,144 |
|
|
$ |
(58,350 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Denominator: |
|
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares outstanding - basic |
|
304,290,590 |
|
|
|
296,360,660 |
|
|
|
302,641,749 |
|
|
|
274,387,532 |
|
Effect of potentially dilutive securities: |
|
|
|
|
|
|
|
|
|
|
|
Stock options |
|
22,377,790 |
|
|
|
30,251,223 |
|
|
|
24,433,580 |
|
|
|
- |
|
Restricted stock units |
|
154,987 |
|
|
|
652,019 |
|
|
|
678,005 |
|
|
|
- |
|
Employee stock purchase plan |
|
57,785 |
|
|
|
56,267 |
|
|
|
20,010 |
|
|
|
- |
|
Weighted-average common shares outstanding - diluted |
|
326,881,152 |
|
|
|
327,320,169 |
|
|
|
327,773,344 |
|
|
|
274,387,532 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per share - basic |
$ |
0.08 |
|
|
$ |
0.09 |
|
|
$ |
0.31 |
|
|
$ |
(0.21 |
) |
Net income (loss) per share - diluted |
$ |
0.07 |
|
|
$ |
0.08 |
|
|
$ |
0.29 |
|
|
$ |
(0.21 |
) |
|
| Schedule of Antidilutive Shares Excluded from Computation of Diluted (Loss) Net Income Per Share |
The following potentially dilutive shares were excluded from the computation of diluted net income per share for the periods presented because including them would have been antidilutive:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
|
Nine Months Ended September 30, |
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
Stock options |
|
2,384,530 |
|
|
|
2,086,437 |
|
|
|
2,188,289 |
|
|
|
33,773,922 |
|
Restricted stock units |
|
15,165 |
|
|
|
- |
|
|
|
60,612 |
|
|
|
1,592,524 |
|
Employee stock purchase plan |
|
7,186 |
|
|
|
- |
|
|
|
34,466 |
|
|
|
244,751 |
|
|